Form 4 for CGTX COGNITION THERAPEUTICS INC
Accepted 2024-02-20 00:00:00 ET · period of report 2024-02-15 · accession 0001062993-24-003651 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-02-20 | 2024-02-15 | CGTX | Doyle John Brendan | CFO | A - Grant | $0.00 | +20.0K | 129.8K | +18% | $0 |
| D | 2024-02-20 | 2024-02-15 | CGTX | Doyle John Brendan | CFO | A - Grant | $0.00 | +20.0K | 20.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-02-15 | A | A | 20,000 | $0.00 | 129,824 | D | — | — | (F1) Each share is represented by a restricted stock unit ("RSU"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock upon settlement. |
| 2 | Derivative | Stock Option (Right to Buy) | 2024-02-15 | A | A | 20,000 | $0.00 | 20,000 | D | $1.98 · — to 2034-02-15 | 20,000 Common Stock | (F2) The option vests 25% on February 15, 2025, with the remaining 75% vesting in 36 equal monthly installments, subject to the Reporting Person's continued service through the applicable vesting dates. |